JP Stock MarketDetailed Quotes

4554 Fuji Pharma

Watchlist
  • 1434
  • +19+1.34%
20min DelayNot Open Jul 23 15:00 JST
35.50BMarket Cap10.14P/E (Static)

Fuji Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Fuji Pharma Earnings Date

Currency: JPY

Period

Q2 FY2024 Earnings

May 9, 2024

Revenue(YoY)

10.64B

+15.31%
EPS(YoY)

62.42

+130.59%
Analyst Rating

Strong Buy

May 22, 2024

Fuji Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.200B--
Aug 8, 20242024/Q3-- / 12.300B--
May 9, 20242024/Q210.642B / 11.254B--
Feb 8, 20242024/Q110.746B / 11.700B--
Nov 9, 20232023/Q411.407B / 11.018B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 12.200B--
Aug 8, 20242024/Q3-- / 12.300B--
May 9, 20242024/Q210.642B / 11.254B--
Feb 8, 20242024/Q110.746B / 11.700B--
Nov 9, 20232023/Q411.407B / 11.018B--

Unlock Free Earnings Estimates

Fuji Pharma Earnings Reports

  • Fuji Pharma: Confirmation letter

    May 10 01:27 ET

  • Fuji Pharma: Quarterly Report - 60th Quarter 2 (2024/01/01 to 2024/03/31)

    May 10 01:27 ET

  • Fuji Pharma: Notice regarding differences between second-quarter earnings forecasts and actual results and partial revisions to full-year earnings forecasts

    May 9 04:00 ET

  • Fuji Pharma: Summary of Financial Results for the 2nd Quarter of the Fiscal Year Ending 2024/9 [Japanese GAAP] (Consolidated)

    May 9 04:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: May 22, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg